Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000959

Drug Information
NamePapaverine    
SynonymsDynovas; Isoquinoline, 6,7-dimethoxy-1-veratryl-(8Cl); Papaverine [BAN]; Papaverinium chloride; Papaverina; Papaverine monohydrochloride; Cardoverina; BSPBio_000426; Papaverine Hcl; NSC136630; Isoquinoline, 6,7-dimethoxy-1-veratryl- (8CI); LS-85584; 6,7-Dimethoxy-1-(3,4-dimethoxybenzyl)isoquinoline; Paveron; CHEMBL19224; Spectrum3_000537; Ro-Papav; Papacon; Papaverine chlorohydrate; RS 47; AB00053515; 1-[(3,4-Dimethoxyphenyl)methyl]6,7-dimethoxyisoquinoline; 4-[(6,7-Dimethoxyisoquinolyl)methyl]-1,2-dimethoxybenzene; Paptial T.R.; Papaverine (BAN); BRD-K15567136-001-01-1; Panergon; KBioSS_000471; Cerebid; Vaso-Pav; BSPBio_002153; NCGC00015810-01; papaverine; 58-74-2; Qua bid; EV1; 1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline; Dilaves; Isoquinoline, 6,7-dimethoxy-1-veratryl-; PAP H; Papanerin-hcl; Paverolan; KBio2_003039; KBio3_001653; Genabid; Prestwick2_000583; Papaverina [Italian]; Ceraspan; KBioGR_000914; TNP00305; Pavatest; nchembio.317-comp11; Papalease; SPBio_002645; Drapavel; Pavagen; NCGC00024428-04; MolPort-000-881-409; Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-; Pamelon; Robaxapap; Pavarine; Vasal; EINECS 200-397-2; Papaverin; Forpavin; InChI=1/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H; BPBio1_000470; Spectrum2_000978; Pavacen; Spectrum_000071; Pavatym; NINDS_000321; IDI1_000321; NCGC00024428-03; Spectrum4_000467; ACon1_002094; Papital T.R.; 1-(3,4-Dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline; Papanerin; Durapav; 6,7-Dimethoxy-1-veratrylisoquinoline; Cardiospan; KBio2_005607; 61-25-6 (hydrochloride); SPBio_001015; Oprea1_810508; AKOS000277460; DB01113; Pavacels; Prestwick3_000583; BRD-K15567136-003-06-6; STOCK1N-09376; DivK1c_000321; Pavatine; Prestwick1_000583; NCGC00015810-04; DB07725; STK039035; Papanerine; Alapav; MEGxp0_001880; WLN: T66 CNJ B1R CO1 DO1& HO1 IO1; Mesotina (TN); S-M-R; 1-((3,4-Dimethoxyphenyl)methyl)-6,7-dimethoxyisoquinoline; NCGC00015810-09; Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-; D07425; Mesotina; Papaversan; NSC35443; Pavabid; UNII-DAA13NKG2Q; Pavnell; Pavabid Hp; Delapav; Cerespan; Lopac-P-3510; NCI60_003183; Oprea1_387689; 5-21-06-00182 (Beilstein Handbook Reference); NCGC00015810-02; KBio2_000471; SDCCGMLS-0003037.P003; 1-{[3,4-bis(methyloxy)phenyl]methyl}-6,7-bis(methyloxy)isoquinoline; Pavacap; AC1L1IPM; AC1Q4CFN; KBio1_000321; CID4680; Pavacot; ZINC00056555; CAS-61-25-6; Myobid; Chlorhydrate de papaverine; Pameion; NSC 136630; Prestwick0_000583; Spectrum5_001188; Papavarine chlorhydrate; 61-25-6; 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline; NCGC00015810-03; Dispamil; Lopac0_000957; ACon1_000238; BAS 00674058; C06533; BRN 0312930    
Trade NameAlbatran; Dicertan; Artegodan; Cardioverina; Dispamil; Opdensit; Panergon; Paverina Houde; Pavacap; Pavadyl; Papaverin-Hamelin; Paveron; Spasmo-Nit; Cardiospan; Papaversan; Cepaverin; Cerespan; Drapavel; Forpaven; Papalease; Pavatest; Paverolan; Therapav; Vasospan; Cerebid; Delapav; Dilaves; Durapav; Dynovas; Optenyl; Pameion; Papacon; Pavabid; Pavacen; Pavakey; Pavased; Pavnell; Alapav; Myobid; Vasal; Pamelon; Pavadel; Pavagen; Ro-Papav; Vaso-Pav; Papanerin-hcl; Qua bid; Papital T.R.; Paptial T.R.; Pap-Kaps-150    
IndicationSpasmApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassVasodilator Agents    
CAS NumberCAS 61-25-6
FormularC20H21NO4    
PubChem Compound IDCID 4680.    
PubChem Substance IDSID 8763.    
SuperDrug ATC IDA03AD01;    
SuperDrug CAS ID000058742;    
TargetcGMP-specific 3',5'-cyclic phosphodiesterase (PDE5)Inhibitor[2]
Ref 1Drug information of Papaverine, 2008 To Reference
Ref 2Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities. Asian J Androl. 2003 Mar;5(1):15-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543